New hope for untreatable cancer pain? Two-Drug combo enters trial
NCT ID NCT07408193
Summary
This study is testing whether a combination of two drugs, lidocaine and ketamine, given through an IV, can better relieve severe, long-term pain caused by cancer in people whose pain isn't helped enough by strong opioid painkillers. It will compare the two-drug infusion to an active placebo (a sedative) in a small group of 24 patients. The goal is to see if this approach provides stronger pain relief and improves daily function for people with this difficult-to-treat pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-REFRACTORY CHRONIC CANCER-RELATED PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University General Hospital of Athens "Attikon" - National and Kapodistrian University of Athens Medical School
Athens, Attica, 12461, Greece
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.